DEPLOYDatabase

Incident · Other

Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade

Rowe v. WHOOP, Inc., No. 3:25-cv-09910 (N.D. Cal.), filed Nov 18 2025, alleges the MG/Life Blood Pressure Insights feature cannot deliver the medical-grade daily systolic/diastolic estimates as advertised, anchored on the July 2025 FDA warning letter. Active litigation; allegations unproven. Pairs with the FDA letter as the BPI marketing-beyond-clearance saga.

Occurred 2025-11-18 · Whoop (5.0 / MG) at Global · Whoop · Global · Biometric wearables

How to read this record

Incident records on DEPLOY are compiled from public sources (regulatory filings, news reports, and operator disclosures) and reflect what has been reported and tracked to date. They are not legal findings, determinations of fault, or safety ratings, and may be updated as new information is verified. See the sources below for the underlying references.
Track Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade

Machine-readable surfaces

Outcomes (1)

  • financial lossreported

Revision history (1)

  • 2026-06-05 · outcome_class

Outcome rows carry verification_posture independently. Revision events carry basis (verified_court_filing, verified_insurance, reported_press, estimate, undisclosed). The framework records outcomes only when verifiable; absence is honest absence, not a claim of no-impact.

Sources (2)

  1. ArentFox Schiff · https://www.afslaw.com/perspectives/alerts/whoop-there-it-fda-warning-letter-now-anchors-class-action-against-whoop
  2. ClassAction.org (complaint) · https://www.classaction.org/media/rowe-v-whoop-inc-complaint.pdf

Common questions

What happened in Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade?
Rowe v. WHOOP, Inc., No. 3:25-cv-09910 (N.D. Cal.), filed Nov 18 2025, alleges the MG/Life Blood Pressure Insights feature cannot deliver the medical-grade daily systolic/diastolic estimates as advertised, anchored on the July 2025 FDA warning letter. Active litigation; allegations unproven. Pairs with the FDA letter as the BPI marketing-beyond-clearance saga.
When did this incident occur?
The incident is recorded as occurring on November 18, 2025 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.
What robot was involved in Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade?
Whoop (5.0 / MG) by Whoop is the recorded robot involved in this incident at Global.
Has anyone responded to Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade?
No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.
What is the current status of Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade?
This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-07-21

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-07-21

Sources by quality tier

2
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Class action (Rowe v. WHOOP) alleges WHOOP falsely advertised BPI as medical-grade.

Deploy Watch

Track this incident.

We notify you when the regulator updates the record, the remedy status changes, or a related incident surfaces.

Canonical ID 77095ec7-8eb0-44aa-a08a-7732f9ab7888